Last reviewed · How we verify
NCT05522179
Nutritional Supplements and Foot Surgery
NA trial testing NutraHeal in Foot Injuries and Disorders in 46 participants. Completed in 30 July 2023.
17 March 2023
Quick facts
| Lead sponsor | NutraHeal |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 46 |
| Start date | 29 August 2022 |
| Primary completion | 17 March 2023 |
| Estimated completion | 30 July 2023 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- NutraHeal
- NutraHeal Plus
Conditions studied
- Foot Injuries and Disorders — all drugs for Foot Injuries and Disorders →
Sponsor
NutraHeal
Who can join
Adults 20 to 80, any sex, with Foot Injuries and Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a prospective randomized trial wherein participants will be assigned to NutraHeal™, NutraHeal Plus™, or standard of care for 1 week prior to foot surgery and 3 weeks after surgery. The central hypothesis is that among patients undergoing surgery, nutritional supplements that maintain energy production, muscle structure, immune function, and response to pain will support recovery from surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05522179
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05522179 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NutraHeal
- Last refreshed: 1 August 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05522179.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing